[Kidney failure, proteinuria, and diabetic nephropathy].
ACE inhibitors and ARA are for the nephrologist two completely unique classes of antihypertensive agents as they offer the opportunity to control microalbuminuria, proteinuria and slow the progression of renal diseases. These properties have mainly been studied in type 1 and type 2 diabetics but can be extended to a wide range of renal diseases. The renal effects of the two classes of compounds differ but the clinical significance of these differences remains to be ascertained.
Collart
F
F
Département de Médecine Interne, H.I.S., Site Etterbeek-Ixelles, U.L.B.
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D003928:Diabetic Nephropathies / Q000188:drug therapy*; D006801:Humans; D011507:Proteinuria / Q000188:drug therapy*; D051437:Renal Insufficiency / Q000188:drug therapy*
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors